CRMD
CorMedix Inc. [CRMD] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CRMD Stock Summary
Top 10 Correlated Stocks
CRMD
In the News
CRMD Financial details
Company Rating
-
Market Cap
320.1M
Income
401.56M
Revenue
29.7K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
40
Optionable
No
Shortable
Yes
Earnings
12 Mar 2024
P/E
0.51
Forward P/E
-
PEG
-0
P/S
6661.89
P/B
2.45
P/C
-
P/FCF
-5.82
Quick Ratio
11.29
Current Ratio
11.61
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
9.16
EPS next Y
-
EPS next Q
-
EPS this Y
-1.33%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-13.29%
Revenue last 5Y
-31.38%
Revenue Q/Q
-
EPS Q/Q
-32%
-
-
-
-
SMA20
5.45%
SMA50
-17.76%
SMA100
-15.14%
Inst Own
-
Inst Trans
-
ROA
439%
ROE
-207%
ROC
-0.5%
Gross Margin
99%
Oper. Margin
-140321%
Profit Margin
1351973%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.57-6.8897
52W High
+52%
52W Low
+356%
RSI
62.22
Rel Volume
1.32
Avg Volume
501.56K
Volume
663.1K
Perf Week
18.9%
Perf Month
-12.89%
Perf Quarter
-8.71%
Perf Half Y
-32.89%
-
-
-
-
Beta
1.847
-
-
Volatility
0.38%, 1.6%
Prev Close
0.66%
Price
9.12
Change
-0.33%
Company Profile
- Volume Average 501.56K
- Market Capitalization 320.1M
- Employee 40
- CEO Mr. Joseph Todisco MBA
- Headquarters Berkeley Heights,NJ,US
- IPO Date 2010-05-13
-
Website
https://www.cormedix.com 
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
